Stay updated on Durvalumab Combinations in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Combinations in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page history shows a new 'Revision: v3.3.3' entry, and the 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' items have been removed. These are minor site-wide updates to footer/metadata and do not affect study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page history now includes a new revision entry v3.3.2 and removes v3.2.0 from the history section; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedA government funding/operating-status notice banner at the top of the page was removed. This change affects page presentation but does not alter the trial's data, status, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check59 days agoChange DetectedThe old and new screenshots show only minor visual/layout tweaks to the Record History page, with no substantive updates to study data or status disclosures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check87 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference10%

- Check95 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

Stay in the know with updates to Durvalumab Combinations in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.